# Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation

> **NCT01517347** · NA · TERMINATED · sponsor: **Peking University People's Hospital** · enrollment: 90 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** Interleukin-2

## Key facts

- **NCT ID:** NCT01517347
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 90 (ACTUAL)
- **Why stopped:** Because the conditional power was 0.083, the Data and Safety Monitoring Board recommended halting the study due to futility after the 1st interim analysis.
- **Last updated:** 2016-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01517347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01517347, "Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01517347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*